UNSPSC 85721852: Revision of autologous tissue substitute in left tarsal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left tarsal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWJ37Z

UNSPSC 85721852 Revision of autologous tissue substitute in left tarsal joint, percutaneous approach is a Commodity code that shows minimal alignment with state and local government procurement activity. The code nominally describes a specific orthopedic surgical procedure, yet the recent opportunities posted under this code do not purchase or solicit autologous tissue substitutes, joint revision services, or related surgical supplies and materials. Instead, the solicitations cover occupational medical surveillance services, independent medical evaluation services for pension disability determinations, pharmacy benefit management administration, temporary health professional staffing for clinical support roles, surgical procedure carve-out network management, and emergency medical services for detained youth—none of which constitute the procurement of autologous tissue products or joint revision procedures that the code's name implies.

The issuing bodies tagged under this code span state departments (Washington State Department of Transportation), county governments (Harris County Juvenile Probation Department, Collier County Board of County Commissioners, County of Santa Clara Health System), and cities (City of Phoenix Retirement Office, City of Long Beach). Geographic activity appears across Washington, Texas, Florida, California, and Arizona. The mismatch between the code's narrow surgical-product scope and the actual work being solicited suggests either misclassification of opportunities by procurement offices or that this code does not represent an active procurement area for state and local governments currently. No recent opportunities in the source actually solicit autologous tissue substitutes, orthopedic implants, surgical materials, or joint revision procedures.